If you would like to learn more about future focusIR related events and roundtables, please submit your details here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSLPE.L Regulatory News (SLPE)

  • There is currently no data for SLPE

Quarterly Trading Statement

20 Sep 2017 07:00

RNS Number : 1924R
Standard Life Private Eqty Trst PLC
20 September 2017
 

Standard Life Private Equity Trust PLC

 

1. Investment update for the quarter ended 30 June 2017

 

· The Company's net asset value ("NAV") per ordinary share increased by 5.9% to 390.6 pence for the quarter ended 30 June 2017

· Realised gains and income during the quarter ended 30 June 2017 were £16.0 million (2.8% of NAV). The unrealised gains on the portfolio on a constant exchange rate basis were £10.0 million (1.8% of NAV); in addition, there were unrealised foreign exchange gains of £8.3 million (1.5% of NAV)

· 93.2% by value of the portfolio was valued by the respective underlying managers at 30 June 2017

· NAV total return was 13.7% for the nine months from 1 October 2016 to 30 June 2017.

· Outstanding commitments were £331.2 million at 30 June 2017

· Liquid resources were £111.6 million at 30 June 2017

 

For the quarter ended 30 June 2017 the Company's NAV increased by 5.9% to 390.6 pence per share, from 368.9 pence per share at 31 March 2017. At 30 June 2017 the Company's net assets were £600.5 million (31 March 2017 - £567.2 million). NAV total return was 13.7% for the nine months from 1 October 2016 to 30 June 2017.

 

The closing value of the Company's portfolio, which, included 50 private equity fund interests, was £488.2 million at 30 June 2017 (31 March 2017 - £470.2 million and 49 private equity fund interests). The total unrealised gains on the portfolio for the quarter ended 30 June 2017 were £18.3 million, comprising £10.0 million of unrealised gains on a constant exchange rate basis and £8.3 million of unrealised foreign exchange gains. The MSCI Europe Index (in sterling) and the FTSE All Share Index (in sterling) rose by 3.7% and 1.4% respectively during the quarter. The unrealised foreign exchange gains were driven by the euro appreciating by 2.6% relative to sterling over the quarter, offset by the US dollar depreciating 3.9% relative to sterling.

 

During the quarter ended 30 June 2017 the Company received £32.1 million of distributions (six months ended 31 March 2017 - £73.5 million) and funded £13.2 million of drawdowns (six months ended 31 March 2017 - £46.1 million). The distributions received during the quarter generated £16.0 million of net realised gains and income, which was equivalent to a return of 2.1 times the acquisition cost of the realised investments. Total distributions and drawdowns for the nine months ended 30 June 2017 were £105.6 million and £59.3 million, respectively.

 

The Company made one new fund commitment of €35.0 million to CVC Capital Partners VII. The Company had total outstanding commitments to its 50 private equity fund interests of £331.2 million at 30 June 2017 (31 March 2017 - £312.2 million and 49 private equity fund interests). The Manager continues to believe that around £60 million of the Company's existing outstanding commitments are unlikely to be drawn.

 

At 30 June 2017 the Company had liquid resources of £111.6 million comprised of cash and cash equivalents (31 March 2017 - liquid resources of £97.7 million). The Company continues to have an undrawn £80 million syndicated revolving credit facility provided by Citibank and Societe Generale that expires in December 2020.

2. Activity since 30 June 2017

 

On 21 July 2017 the Company paid an interim dividend for the year ended 30 September 2017 of 6.0 pence per ordinary share. The cost of the interim dividend was £9.2 million.

 

During the period from 1 July to 8 September 2017 the Company funded £24.0 million of drawdowns and received £21.1 million of distributions.

 

A new commitment of €30.0 million was made to Nordic Capital Fund IX on 29 August. At 8 September 2017 the Company had liquid resources of £101.9 million. The Company also had total outstanding commitments of £344.9 million.

 

The Company's estimated NAV at 31 August 2017 is also being announced today. It is anticipated that the Company will release its preliminary announcement for the financial year ending 30 September 2017 on or around 4 December 2017.

 

 

For further information please contact:-

 

Roger Pim at SL Capital Partners LLP (0131 245 0055)

 

Note:-

Standard Life Private Equity Trust PLC is an investment company managed by SL Capital Partners LLP, the ordinary shares of which are admitted to listing by the UK Listing Authority and to trading on the Stock Exchange and which seeks to conduct its affairs so as to qualify as an investment trust under sections 1158-1165 of the Corporation Tax Act 2010. The Board of Standard Life Private Equity Trust PLC is independent of Standard Life Aberdeen plc.

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTXKLFFDKFXBBQ
Date   Source Headline
16th Mar 20117:30 amRNSQuarterly Trading Statement
31st Jan 20113:54 pmRNSDirector/PDMR Shareholding
31st Jan 20113:53 pmRNSDirector/PDMR Shareholding
31st Jan 201111:50 amRNSTotal Voting Rights
31st Jan 201111:03 amRNSDirector/PDMR Shareholding
27th Jan 201111:03 amRNSAnnual Financial Report
26th Jan 20119:33 amRNSIssue of Equity
25th Jan 20114:08 pmRNSResult of AGM
25th Jan 20111:00 pmRNSInterim Management Statement
17th Jan 201111:28 amRNSDirector/PDMR Shareholding
6th Jan 20112:05 pmRNSCalculation of Script Dividend Reference Price
6th Jan 201111:28 amRNSQuarterly Disclosure
21st Dec 201011:07 amRNSDoc re. Annual Report
20th Dec 20104:26 pmRNSAnnual Information Update
8th Dec 20104:02 pmRNSDirector/PDMR Shareholding
6th Dec 20107:00 amRNSPreliminary Results for year to 30/09/10
2nd Dec 20102:30 pmRNSDirectorate Change
30th Nov 20107:00 amRNSRefinancing of debt facility
17th Nov 20109:20 amRNSDirector Declaration
4th Oct 20102:45 pmRNSQuarterly Disclosure
30th Sep 20105:30 pmRNSTotal Voting Rights
28th Sep 201010:46 amRNSApplication for Listing
22nd Sep 20107:00 amRNSInvestment update for quarter to 30 June 2010
10th Aug 201012:49 pmRNSInterim Management Statement
2nd Jun 201012:36 pmRNSHolding(s) in Company
28th May 20107:00 amRNSHalf Yearly Report
9th Apr 201012:46 pmRNSHolding(s) in Company
17th Mar 20107:00 amRNSTrading Statement
9th Feb 201011:40 amRNSDirector/PDMR Shareholding
8th Feb 201010:19 amRNSDirector/PDMR Shareholding
2nd Feb 20103:02 pmRNSDirector/PDMR Shareholding
1st Feb 201011:14 amRNSDirector/PDMR Shareholding
1st Feb 201011:12 amRNSDirector/PDMR Shareholding
1st Feb 201011:10 amRNSDirector/PDMR Shareholding
1st Feb 201011:06 amRNSTotal Voting Rights
27th Jan 20103:39 pmRNSResult of AGM
27th Jan 201012:13 pmRNSInterim Management Statement
27th Jan 201010:00 amRNSApplication for Listing
20th Jan 20109:47 amRNSHolding(s) in Company
14th Jan 201011:30 amRNSAnnual Financial Report
12th Jan 201010:39 amRNSAnnual Information Update
7th Jan 20104:41 pmRNSCalculation of scrip dividend reference price
5th Jan 201012:46 pmRNSQuarterly Disclosure
23rd Dec 200910:57 amRNSDirector/PDMR Shareholding - Replacement
17th Dec 20092:25 pmRNSDoc re. Annual Report and Circular
3rd Dec 200912:13 pmRNSDirector/PDMR Shareholding
3rd Dec 20097:00 amRNSPreliminary results for year to 30/9/09
18th Sep 20097:00 amRNSThird Quarter Trading Statement
29th Jul 20097:30 amRNSInterim Management Statement
8th Jul 20092:23 pmRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.